PPA
JNCE

Parametric Portfolio Associates’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Parametric Portfolio Associates’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$101K Buy
14,942
+24
+0.2% +$171 ﹤0.01% 3560
2021
Q4 		$125K Buy
14,918
+546
+4% +$4.5K ﹤0.01% 3520
2021
Q3 		$107K Buy
14,372
+2,793
+24% +$17.3K ﹤0.01% 3528
2021
Q2 		$79K Sell
11,579
-208
-2% -$1.73K ﹤0.01% 3506
2021
Q1 		$121K Sell
11,787
-473
-4% -$5.18K ﹤0.01% 3951
2020
Q4 		$86K Sell
12,260
-1,014
-8% -$7.89K ﹤0.01% 3898
2020
Q3 		$108K Sell
13,274
-19,201
-59% -$119K ﹤0.01% 3782
2020
Q2 		$224K Buy
32,475
+15,497
+91% +$83.6K ﹤0.01% 3593
2020
Q1 		$81K Sell
16,978
-1,626
-9% -$9.36K ﹤0.01% 3764
2019
Q4 		$162K Sell
18,604
-2,158
-10% -$11.7K ﹤0.01% 3782
2019
Q3 		$69K Buy
20,762
+1,915
+10% +$7.67K ﹤0.01% 3877
2019
Q2 		$93K Sell
18,847
-2,417
-11% -$12.8K ﹤0.01% 3850
2019
Q1 		$132K Buy
21,264
+9,488
+81% +$45.8K ﹤0.01% 3778
2018
Q4 		$40K Buy
+11,776
New +$55K ﹤0.01% 3864
2018
Q3 		– Sell
-46,230
Closed -$354K – 3981
2018
Q2 		$354K Buy
+46,230
New +$667K ﹤0.01% 3492

Other funds holding JNCE

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return